Lexington, Mass.-based T2 Biosystems Inc. priced an underwritten registered public offering of 6.1 million common shares at $7.50 per share.
T2 Biosystems expects $45.8 million in gross proceeds from the offering, which is expected to close by June 4.
Leerink Partners LLC is acting as the book-running manager for the offering while Canaccord Genuity LLC is acting as the passive book-running manager.
Janney Montgomery Scott LLC, JonesTrading Institutional Services LLC and WBB Securities LLC are acting as co-managers.
The underwriters can buy up to an additional 915,000 common shares from the company.
